Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for China Pharma Holdings (CPHI) over the last 12 years, with Q3 2025 value amounting to $158076.0.

  • China Pharma Holdings' Depreciation and Depletion fell 6794.76% to $158076.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $800921.0, marking a year-over-year decrease of 6663.11%. This contributed to the annual value of $2.2 million for FY2024, which is 1419.2% down from last year.
  • China Pharma Holdings' Depreciation and Depletion amounted to $158076.0 in Q3 2025, which was down 6794.76% from $163503.0 recorded in Q2 2025.
  • Over the past 5 years, China Pharma Holdings' Depreciation and Depletion peaked at $966956.0 during Q3 2021, and registered a low of $158076.0 during Q3 2025.
  • Moreover, its 5-year median value for Depreciation and Depletion was $636721.0 (2024), whereas its average is $569004.2.
  • Per our database at Business Quant, China Pharma Holdings' Depreciation and Depletion soared by 4553.82% in 2021 and then plummeted by 7432.11% in 2025.
  • Quarter analysis of 5 years shows China Pharma Holdings' Depreciation and Depletion stood at $701100.0 in 2021, then dropped by 10.03% to $630781.0 in 2022, then grew by 0.44% to $633577.0 in 2023, then crashed by 51.43% to $307741.0 in 2024, then plummeted by 48.63% to $158076.0 in 2025.
  • Its last three reported values are $158076.0 in Q3 2025, $163503.0 for Q2 2025, and $171601.0 during Q1 2025.